GODREJIND2025-04-012025-06-30GODREJIND2025-04-012025-06-30in-capmkt:OtherExpenses1MemberGODREJIND2025-04-012025-06-30

ItemsThatWillNotBeReclassifiedToProfitAndLoss1

GODREJIND2025-04-012025-06-30

ItemsThatWillBeReclassifiedToProfitAndLoss1

GODREJIND2025-04-012025-06-30

AuditorDomain1

iso4217:INRxbrli:pureiso4217:INRxbrli:shares

500164

GODREJIND

NOTLISTED

INE233A01035

GODREJ INDUSTRIES LIMITED

Main Board

Equity

2025-04-01

2026-03-31

2025-08-13

2025-08-06

INR

Crores

Quarterly

First quarter

Single segment

The Company has presented segment information in the Consolidated financial statement which are presented in the same financial report. Accordingly in terms of Ind AS 108 Operating Segments no disclosures related to segments are presented in Standalone financial statements.

2025-08-13

12:30:00

2025-08-13

13:40:00

Declaration of unmodified opinion

false

2025-04-01

2025-06-30

Unaudited

Standalone

10182900000

423800000

10606700000

6883200000

297300000

-500000000

534300000

2095200000

230300000

1366200000

10906500000

-299800000

-10300000

-310100000

336800000

-0.89

0.0628

0.002

0.0097

Notes: 1. The above Statement of unaudited financial results which are published in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 13, 2025. The financial results are in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with the relevant rules thereunder. The above results have been reviewed by the Statutory Auditors of the Company who have expressed an unmodified review conclusion vide their review reports thereon. 2. During the quarter ended June 30, 2025, under the Employee Stock Grant Scheme, the Company has granted 35,712 stock grants to eligible employees of the Company. Upon vesting, as per the Scheme, equivalent number of equity shares of nominal value of Re. 1 each in the Company shall be issued to the eligible employees on exercising their grants. 3. The Board of Directors of Astec LifeSciences Limited (Subsidiary Company of Godrej Agrovet Limited) at its meeting held on June 30, 2025, has inter-alia, approved the Letter of Offer and Rights Issue of 28,01,673 (Twenty Eight Lakh One Thousand Six Hundred and Seventy-Three) fully paid-up Equity Shares of face value of Rs. 10 (Ten) each, for an aggregate amount not exceeding Rs. 249.35 Crore (Rupees Two Hundred and Forty-Nine Crore and Thirty Five Lakh Only) at the issue price of Rs. 890/- (Rupees Eight Hundred and Ninety Only) per share in the Rights Entitlement ratio of 1 (One) fully paid-up rights equity share for every 7 (Seven) fully paid up equity share, of face value Rs. 10 (Ten) each, held by the eligible equity shareholders of Astec LifeSciences Limited as on Record date, July 04, 2025. The Issue opened on Monday, July 14, 2025 and closed on Monday, July 28, 2025. Other terms of the Issue were included in the Letter of Offer for the Issue. Accordingly, Godrej Agrovet Limited a subsidiary company has participated in the said Rights issue and equity shares have been allotted on July 29, 2025. Consequent to the rights issue, the shareholding % in Astec LifeSciences Limited has increased to 67.03%. 4. Pursuant to SEBI Circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 read with Circular no. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 dated July 29, 2022, the Company and its subsidiary(ies) have listed Commercial Papers and listed Unsecured Non convertible debentures on concerned Stock Exchange(s). 5. Formulae used for Calculation of Key Ratios and Financial indicators: Debt Equity Ratio (Gross) = Total Debt /Equity Debt Equity Ratio (Net) = DEBT [Borrowings (excluding Lease Liabilities accounted as per Ind AS 116) - Cash and Bank Balance (includes FD) - Liquid Investments] / Equity Debt Service Coverage Ratio = EBITDA / [Interest Expense + Repayment of Long Term Borrowings during the period (netted off to the extent of Long term Loans availed during the same period for the repayments)] Interest Service Coverage Ratio = EBITDA / Interest Expense EBITDA = Net Profit/(Loss) Before Tax + Interest Expense + Depreciation and Amortisation Expenses+Loss/(Profit) (net) on sale of Property, Plant and Equipment Current Ratio = Current Assets/Current Liabilities Long term Debt to Working Capital = Non Current Borrowing / (Current assets-Current Liabilities) Bad Debts to Accounts Receivable Ratio = Bad Debts/Accounts Receivable Current Liability Ratio = Current Liabilities /Total Liabilities Total Debt to Total Assets = (Non Current Borrowing+Current Borrowing)/Total Assets Debtors Turnover = Revenue from Operations / Average Trade Receivable Inventory Turnover = (Cost of Materials Consumed + Purchases of Stock in Trade + Changes in Inventories of Finished Goods, Stock in Trade and Work in Progress) / Average Inventory Operating profit ratio = (Earnings before exceptional item, interest, taxes, depreciation, amortization expenses less Other Income/ Revenue from operations) Net Profit Margin = Profit/(Loss) for the period/ Revenue from Operations Net Worth= As defined in sub-section (57) of section 2 of the Companies Act,2013. 6. The Company is in compliance with the requirements of the Chapter XII of SEBI operational circular dated August 10, 2021 (updated as on April 13, 2022) applicable to Large Corporate Borrowers. 7. The figures for the quarter ended March 31, 2025 are the balancing figures between the audited figures in respect of the full financial year and the published year to date figures upto the third quarter of the financial year. For Table refer PDF filing done at Stock exchanges.

Other Expenses

1366200000

Amount of items that will not be reclassified to profit and loss

-10300000

Amount of items that will be reclassified to profit and loss

-10300000

Unaudited

true

Kalyaniwalla & Mistry LLP

true

2027-07-31